Original BioMedicals Co., Ltd. (TPEX:6483)

Taiwan flag Taiwan · Delayed Price · Currency is TWD
12.20
-0.95 (-7.22%)
Jul 14, 2026, 1:38 PM CST
Market Cap795.74M -13.4%
Revenue (ttm)381.00K
Net Income-101.51M
EPS-1.53
Shares Out 66.59M
PE Ration/a
Forward PEn/a
Dividendn/a
Ex-Dividend Daten/a
Volume1
Open12.65
Previous Close13.15
Day's Range11.75 - 13.15
52-Week Range9.12 - 20.00
Beta0.23
Analystsn/a
Price Targetn/a
Earnings DateAug 10, 2026

About Original BioMedicals

Original BioMedicals Co., Ltd. engages in the development of drugs in Taiwan. The company develops OBM-A01, a radiation injury prevention and therapeutic drug for the treatment of acute radiation injuries, including nuclear radiation and solar radiation exposure in space; OBM-B01, a cyanide compound drug for protection against toxic gases from fires; CCM-CL, a cyclic polypeptide antibiotic; and Iron Dextran, an injection for the treatment of iron deficiency. It also provides NE (vitamin C+E) and NE Butorphanol, as well as technical services. Or... [Read more]

Sector Healthcare
Founded 2011
Employees 25
Stock Exchange Taipei Exchange
Ticker Symbol 6483
Full Company Profile

Financial Performance

Financial Statements